Email This Press Releases

NASDAQ:KRBP Long Term Investor Alert: Investigation over Possible Wrongdoing at Kiromic BioPharma, Inc.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Kiromic BioPharma, Inc..

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy